Mark Cain
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,098 and has fallen 88.6% since, to $125 in 2025. That places this record below the midpoint for urology clinicians in GA, where the typical reported total is $4,062.
Across 119 payments — averaging $26.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Procept Biorobotics Corporation$435
- Astellas Pharma US Inc$282
- Teleflex LLC$262
- AbbVie$228
- Boston Scientific$226
- Bayer$204
- plus $2K from 26 others
What the payments were for
- Food & beverage$3,190100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Procept Biorobotics Corporation | 3 | $435 |
| Astellas Pharma US Inc | 17 | $282 |
| Teleflex LLC | 3 | $262 |
| AbbVie(2 entities) | 13 | $228 |
| Boston Scientific | 6 | $226 |
| Bayer | 10 | $204 |
| Johnson & Johnson | 14 | $194 |
| Myovant Sciences Inc. | 6 | $193 |
| Pfizer | 7 | $151 |
| Axonics, Inc. | 3 | $138 |
| Urovant Sciences Inc | 1 | $109 |
| Urogen Pharma, Inc. | 1 | $97 |
| Cook Medical LLC | 1 | $96 |
| Sumitomo Pharma America, Inc. | 3 | $60 |
| Blue Earth Diagnostics | 2 | $56 |
| AstraZeneca | 2 | $50 |
| Rochester Medical Corporation | 2 | $42 |
| Clarus Therapeutics Inc. | 3 | $42 |
| Novartis | 2 | $38 |
| Coloplast | 2 | $37 |
| Dentsply IH Inc. | 1 | $36 |
| Accord Healthcare, Inc. | 1 | $31 |
| Endo Pharmaceuticals Inc. | 2 | $31 |
| Antares Pharma, Inc. | 2 | $27 |
| Merck | 2 | $27 |
| Travere Therapeutics, Inc. | 4 | $21 |
| Laborie Medical Technologies Corp. | 1 | $18 |
| Smith+Nephew | 1 | $15 |
| Acerus Pharmaceuticals Corporation | 1 | $14 |
| Cardinal Health 414 LLC | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Ambu Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,199 in reported general payments places this provider in the 45th percentile of 369 urology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 74 | $1,648 |
| Finasteride | 67 | $853 |
Paid to pharmacies, not to this prescriber.
Other urology in Evans
- Vahan KassabianRoswell$1.6M
- Lewis KritemanRoswell$864K
- Daniel CanterDecatur$329K
- Tariq HakkyAtlanta$140K
- Sherita KingAugusta$108K
- Brittani Barrett-HarlowFayetteville$100K
- James BennettAtlanta$93K
- Anthony BarnesAtlanta$89K
- Scott MillerRoswell$85K
- Matthew SandAtlanta$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.